Analysis of CHRNA3 and CHRNA5 Gene Expression Related to Nicotine Addiction
Author Information
Author(s): Doyle Glenn A., Wang Min-Jung, Chou Andrew D., Oleynick John U., Arnold Steven E., Buono Russell J., Ferraro Thomas N., Berrettini Wade H.
Primary Institution: University of Pennsylvania
Hypothesis
Do CHRNA5 or CHRNA3 promoter haplotypes influence allelic expression levels associated with nicotine addiction?
Conclusion
CHRNA5 promoter variants may affect the relative risk for nicotine addiction in some individuals.
Supporting Evidence
- Genome-wide association studies implicate variations in CHRNA5 and CHRNA3 as being associated with nicotine addiction.
- Allelic expression imbalance was observed in post-mortem brain tissue from individuals heterozygous at coding polymorphisms in CHRNA3 or CHRNA5.
- CHRNA5 promoter haplotypes showed statistically significant differences in relative promoter activity.
Takeaway
This study looked at how certain genes related to nicotine addiction work in the body, finding that some gene variations can change how much these genes are expressed.
Methodology
The study involved in vitro analysis using luciferase reporter vectors in BE(2)-C cells and ex vivo analysis of post-mortem brain tissue.
Potential Biases
Potential bias due to the selection of post-mortem brain samples and the exclusion criteria for subjects.
Limitations
The study was limited to individuals of European ancestry and may not generalize to other populations.
Participant Demographics
Participants were individuals of European ancestry, with exclusions for various health conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website